Atezolizumab plus platinum-based regimen and bevacizumab: is it time to consider immunotherapy in a concurrent approach for lung cancer?

Detalles Bibliográficos
Autores principales: Bianco, Andrea, Campbell, Susan F. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797422/
https://www.ncbi.nlm.nih.gov/pubmed/35117074
http://dx.doi.org/10.21037/tcr.2018.11.06

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797422/
https://www.ncbi.nlm.nih.gov/pubmed/35117074
http://dx.doi.org/10.21037/tcr.2018.11.06

Ejemplares similares